XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.53%2.14B | 12.52%541.13M | 9.84%543.34M | 7.28%540.98M | 8.58%512.36M | 5.49%1.95B | 6.35%480.93M | 4.54%494.68M | 7.59%504.28M | 3.45%471.85M |
Operating revenue | 9.53%2.14B | 12.52%541.13M | 9.84%543.34M | 7.28%540.98M | 8.58%512.36M | 5.49%1.95B | 6.35%480.93M | 4.54%494.68M | 7.59%504.28M | 3.45%471.85M |
Cost of revenue | 10.21%1.2B | 13.55%304.31M | 13.49%305.88M | 7.85%303.16M | 6.13%288.69M | 2.28%1.09B | 3.52%268.01M | 0.37%269.52M | 2.13%281.1M | 3.16%272.02M |
Gross profit | 8.67%935.76M | 11.22%236.82M | 5.46%237.46M | 6.56%237.82M | 11.92%223.67M | 9.85%861.1M | 10.13%212.93M | 10.02%225.16M | 15.37%223.18M | 3.86%199.84M |
Operating expense | -0.98%636.24M | -0.03%165.13M | -4.09%154.63M | -0.94%159.78M | 1.18%156.69M | 12.81%642.56M | 8.23%165.18M | 12.16%161.23M | 18.01%161.3M | 13.41%154.86M |
Selling and administrative expenses | 0.07%458.67M | 1.84%121.88M | -3.28%110.66M | 1.92%116.99M | -0.30%109.14M | 13.71%458.35M | 17.51%119.68M | 10.42%114.42M | 15.13%114.78M | 11.82%109.46M |
-Selling and marketing expense | 5.32%157.73M | 4.71%41.54M | 6.42%38.2M | 12.03%41.57M | -1.82%36.43M | 10.33%149.77M | 13.44%39.67M | 6.56%35.9M | 16.38%37.1M | 5.39%37.1M |
-General and administrative expense | -2.47%300.94M | 0.42%80.35M | -7.72%72.46M | -2.91%75.42M | 0.48%72.71M | 15.43%308.58M | 19.63%80.02M | 12.28%78.52M | 14.54%77.68M | 15.43%72.36M |
Research and development costs | 7.62%117.94M | 12.50%29.44M | 6.50%30.12M | 2.83%28.95M | 9.06%29.43M | 4.18%109.59M | -19.91%26.16M | 12.27%28.28M | 20.38%28.15M | 12.72%26.99M |
Depreciation amortization depletion | -20.11%59.63M | -28.54%13.81M | -25.24%13.85M | -24.62%13.85M | -1.57%18.12M | 21.62%74.63M | 6.78%19.33M | 23.99%18.53M | 35.00%18.37M | 25.10%18.41M |
-Depreciation and amortization | -20.11%59.63M | -28.54%13.81M | -25.24%13.85M | -24.62%13.85M | -1.57%18.12M | 21.62%74.63M | 6.78%19.33M | 23.99%18.53M | 35.00%18.37M | 25.10%18.41M |
Operating profit | 37.06%299.53M | 50.13%71.69M | 29.55%82.83M | 26.12%78.04M | 48.91%66.98M | 2.00%218.54M | 17.29%47.75M | 4.96%63.94M | 9.02%61.87M | -19.49%44.98M |
Net non-operating interest income expense | 74.90%-5.93M | 66.43%-1.26M | 78.74%-1.24M | 80.38%-1.25M | 71.58%-2.18M | 16.74%-23.63M | 53.72%-3.75M | 37.27%-5.81M | -2.78%-6.39M | -59.95%-7.68M |
Non-operating interest expense | -74.90%5.93M | -66.43%1.26M | -78.74%1.24M | -80.38%1.25M | -71.58%2.18M | -16.74%23.63M | -53.72%3.75M | -37.27%5.81M | 2.78%6.39M | 59.95%7.68M |
Other net income (expense) | 337.86%14.57M | 872.39%6.34M | 472.30%4.5M | 192.85%1.88M | 48.07%1.85M | 93.15%3.33M | -35.51%652K | 500.76%787K | 197.69%643K | 242.31%1.25M |
Other non- operating income (expenses) | 337.86%14.57M | 872.39%6.34M | 472.30%4.5M | 192.85%1.88M | 48.07%1.85M | 93.15%3.33M | -35.51%652K | 500.76%787K | 197.69%643K | 242.31%1.25M |
Income before tax | 55.45%308.17M | 71.93%76.77M | 46.14%86.1M | 40.15%78.67M | 72.90%66.64M | 5.67%198.24M | 32.81%44.65M | 13.76%58.91M | 10.58%56.13M | -25.06%38.54M |
Income tax | 39.68%45.14M | 100.90%11.55M | -14.32%10.2M | 56.10%10.93M | 62.63%12.47M | 38.38%32.32M | 126.08%5.75M | 922.60%11.9M | -35.26%7M | -33.00%7.67M |
Net income | 58.53%263.03M | 67.65%65.22M | 61.45%75.9M | 37.88%67.74M | 75.45%54.17M | 1.02%165.92M | 25.18%38.9M | -11.69%47.01M | 22.99%49.13M | -22.78%30.88M |
Net income continuous Operations | 58.53%263.03M | 67.65%65.22M | 61.45%75.9M | 37.88%67.74M | 75.45%54.17M | 1.02%165.92M | 25.18%38.9M | -11.69%47.01M | 22.99%49.13M | -22.78%30.88M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 58.53%263.03M | 67.65%65.22M | 61.45%75.9M | 37.88%67.74M | 75.45%54.17M | 1.02%165.92M | 25.18%38.9M | -11.69%47.01M | 22.99%49.13M | -22.78%30.88M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 58.53%263.03M | 67.65%65.22M | 61.45%75.9M | 37.88%67.74M | 75.45%54.17M | 1.02%165.92M | 25.18%38.9M | -11.69%47.01M | 22.99%49.13M | -22.78%30.88M |
Basic earnings per share | 56.20%6.17 | 65.22%1.52 | 58.93%1.78 | 35.90%1.59 | 72.97%1.28 | 0.00%3.95 | 22.67%0.92 | -12.50%1.12 | 21.88%1.17 | -23.71%0.74 |
Diluted earnings per share | 55.93%6.05 | 63.74%1.49 | 58.18%1.74 | 36.52%1.57 | 72.60%1.26 | 0.26%3.88 | 24.66%0.91 | -12.70%1.1 | 22.34%1.15 | -22.34%0.73 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |